DarioHealth falls on weak Q2 revenue

DarioHealth

15/08/2022 18:42

** Shares of DarioHealth Corp  DRIO.O  decline 11.5% to
$6.34 - set for biggest pct fall in nearly a year
    ** Digital therapeutics company reports Q2 revenue of $6.2
mln, lower than Refinitiv IBES estimates of $8.2 mln, as co
shifts focus away from its legacy direct-to-consumer (DTC)
business  urn:newsml:reuters.com:*:nPnbz6Hhca
    ** Says co is prioritizing its other business model,
business to business to consumer (B2B2C), in which companies
reach customers via third party, usually an e-commerce platform
    ** Sees impact on revenue from the shift to be temporary,
expecting continued strong demand for B2B2C solutions to more
than offset the decrease in DTC revenue
    ** Including session's fall, stock down ~51% YTD

 (Reporting by Raghav Mahobe)
 ((Raghav.Mahobe@thomsonreuters.com;))